Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Hepatitis B Antibodies"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 21-40 z 967
Tytuł:
Atypical Hepatitis B Virus Serology Profile-Hepatitis B Surface Antigen-Positive/Hepatitis B Core Antibody-Negative-In Hepatitis B Virus/HIV Coinfected Individuals in Botswana.
Autorzy:
Phinius BB; Botswana Harvard AIDS Institute Partnership, Private Bag BO 320, Gaborone, Botswana.; School of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Private Bag UB 0022, Gaborone, Botswana.
Anderson M; Botswana Harvard AIDS Institute Partnership, Private Bag BO 320, Gaborone, Botswana.
Mokomane M; School of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Private Bag UB 0022, Gaborone, Botswana.
Gobe I; School of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Private Bag UB 0022, Gaborone, Botswana.
Choga WT; Botswana Harvard AIDS Institute Partnership, Private Bag BO 320, Gaborone, Botswana.; School of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Private Bag UB 0022, Gaborone, Botswana.
Ratsoma T; Botswana Harvard AIDS Institute Partnership, Private Bag BO 320, Gaborone, Botswana.
Phakedi B; Botswana Harvard AIDS Institute Partnership, Private Bag BO 320, Gaborone, Botswana.
Mpebe G; Botswana Harvard AIDS Institute Partnership, Private Bag BO 320, Gaborone, Botswana.
Ditshwanelo D; Botswana Harvard AIDS Institute Partnership, Private Bag BO 320, Gaborone, Botswana.
Musonda R; Botswana Harvard AIDS Institute Partnership, Private Bag BO 320, Gaborone, Botswana.
Makhema J; Botswana Harvard AIDS Institute Partnership, Private Bag BO 320, Gaborone, Botswana.; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA 02115, USA.
Moyo S; Botswana Harvard AIDS Institute Partnership, Private Bag BO 320, Gaborone, Botswana.; School of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Private Bag UB 0022, Gaborone, Botswana.; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA 02115, USA.; School of Health Systems and Public Health, University of Pretoria, Private Bag X20, Hatfield, Pretoria 0028, South Africa.
Gaseitsiwe S; Botswana Harvard AIDS Institute Partnership, Private Bag BO 320, Gaborone, Botswana.; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA 02115, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Jul 13; Vol. 15 (7). Date of Electronic Publication: 2023 Jul 13.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections*/complications
HIV Infections*/epidemiology
Hepatitis B*/diagnosis
Hepatitis B*/epidemiology
Coinfection*
Humans ; Female ; Hepatitis B virus/genetics ; Hepatitis B Surface Antigens ; Botswana/epidemiology ; DNA, Viral ; Hepatitis B Antibodies ; Hepatitis B Core Antigens
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Reduced protective efficacy of hepatitis B vaccine among fully vaccinated children in Ethiopia.
Autorzy:
Adugna A; Medical Laboratory Science, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia.
Demeke G; Medical Laboratory Science, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia.
Toru M; Medical Laboratory Science, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia.
Tsehay D; Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Esmael A; Medical Laboratory Science, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia.
Mihret A; Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Mulu A; Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Jul 07; Vol. 18 (7), pp. e0288355. Date of Electronic Publication: 2023 Jul 07 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B Vaccines*/therapeutic use
Hepatitis B Surface Antigens*
Infant, Newborn ; Female ; Humans ; Child ; Child, Preschool ; Ethiopia/epidemiology ; Cross-Sectional Studies ; Seroepidemiologic Studies ; Hepatitis B virus ; Vaccination/methods ; Hepatitis B Antibodies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
No Hepatitis Delta Virus Seropositivity among Blood Donors with Overt and Occult Hepatitis B Infection in Dalian, Liaoning Province, China.
Autorzy:
Deng X; Dalian Blood Center, No. 90 Yan'an Road, Zhongshan District, Dalian 116001, China.
Liu D; Dalian Blood Center, No. 90 Yan'an Road, Zhongshan District, Dalian 116001, China.
Delcourt MP; Department of Virology, Henri Mondor Hospital, Paris-Est University, Inserm U955-IMRB-Team 18, 94010 Creteil, France.
Gao H; Dalian Blood Center, No. 90 Yan'an Road, Zhongshan District, Dalian 116001, China.
Zhou L; Dalian Blood Center, No. 90 Yan'an Road, Zhongshan District, Dalian 116001, China.
Candotti D; Department of Virology, Henri Mondor Hospital, Paris-Est University, Inserm U955-IMRB-Team 18, 94010 Creteil, France.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Jul 06; Vol. 15 (7). Date of Electronic Publication: 2023 Jul 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis B, Chronic*
Hepatitis B*
Humans ; Hepatitis B Surface Antigens ; Hepatitis Delta Virus/genetics ; Blood Donors ; DNA, Viral/genetics ; Hepatitis B virus/genetics ; Hepatitis B Antibodies ; China/epidemiology ; Immunoglobulin G
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
World Hepatitis day 2021 -screening and vaccination against Hepatitis B virus in Accra, Ghana.
Autorzy:
Kusi KA; Department of Immunology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon Accra, Ghana.; Department of Virology, Noguchi Memorial Noguchi Memorial Institute for Medical Research, University of Ghana, Legon Accra, Ghana.
van der Puije W; Department of Immunology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon Accra, Ghana.
Asandem DA; Department of Immunology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon Accra, Ghana.; Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Legon Accra, Ghana.; Department of Virology, Noguchi Memorial Noguchi Memorial Institute for Medical Research, University of Ghana, Legon Accra, Ghana.
Baba-Adam R; Department of Immunology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon Accra, Ghana.; Department of Virology, Noguchi Memorial Noguchi Memorial Institute for Medical Research, University of Ghana, Legon Accra, Ghana.
Agbevey H; Department of Immunology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon Accra, Ghana.
Asare B; Department of Immunology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon Accra, Ghana.; Department of Animal Biology and Conservation Science, University of Ghana, Legon Accra, Ghana.
Segbefia P; Department of Immunology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon Accra, Ghana.; Department of Theoretical Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Bentum-Ennin L; Department of Immunology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon Accra, Ghana.
Annan A; Department of Immunology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon Accra, Ghana.
Osei F; Department of Immunology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon Accra, Ghana.
Teye-Adjei D; Department of Immunology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon Accra, Ghana.
Galevo ES; Department of Immunology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon Accra, Ghana.
Odame G; University Hospital, University of Ghana, Legon Accra, Ghana.
Ansa G; University Hospital, University of Ghana, Legon Accra, Ghana.
Amoah L; Department of Immunology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon Accra, Ghana.; Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Legon Accra, Ghana.
Bonney JHK; Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Legon Accra, Ghana. .; Department of Virology, Noguchi Memorial Noguchi Memorial Institute for Medical Research, University of Ghana, Legon Accra, Ghana. .
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2023 Jun 16; Vol. 23 (1), pp. 1164. Date of Electronic Publication: 2023 Jun 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis B*/diagnosis
Hepatitis B*/epidemiology
Hepatitis B*/prevention & control
Hepatitis A*
Adult ; Male ; Female ; Humans ; Adolescent ; Young Adult ; Middle Aged ; Aged ; Hepatitis B virus ; Hepatitis B Surface Antigens ; Ghana/epidemiology ; Hepatitis B Vaccines ; Hepatitis B Antibodies ; Vaccination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Hepatitis B Core Antibody Level: A Surrogate Marker for Host Antiviral Immunity in Chronic Hepatitis B Virus Infections.
Autorzy:
Shi Y; State Key Laboratory of Infectious Disease Vaccine Development, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen 361102, China.; NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, National Institute of Diagnostics Vaccine Development in Infectious Diseases, School of Public Health, Xiamen 361102, China.
Wang Z; State Key Laboratory of Infectious Disease Vaccine Development, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen 361102, China.; NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, National Institute of Diagnostics Vaccine Development in Infectious Diseases, School of Public Health, Xiamen 361102, China.
Ge S; State Key Laboratory of Infectious Disease Vaccine Development, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen 361102, China.; NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, National Institute of Diagnostics Vaccine Development in Infectious Diseases, School of Public Health, Xiamen 361102, China.
Xia N; State Key Laboratory of Infectious Disease Vaccine Development, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen 361102, China.; NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, National Institute of Diagnostics Vaccine Development in Infectious Diseases, School of Public Health, Xiamen 361102, China.
Yuan Q; State Key Laboratory of Infectious Disease Vaccine Development, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen 361102, China.; NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, National Institute of Diagnostics Vaccine Development in Infectious Diseases, School of Public Health, Xiamen 361102, China.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 May 03; Vol. 15 (5). Date of Electronic Publication: 2023 May 03.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis B, Chronic*
Hepatitis B*
Humans ; Antiviral Agents/therapeutic use ; Hepatitis B virus/genetics ; Hepatitis B Antibodies ; Hepatitis B Core Antigens ; Biomarkers ; Hepatitis B Surface Antigens ; DNA, Viral
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Levels of hepatitis B antibody titers are affected by age and doses gap time in children from a high endemic area of the western Amazon.
Autorzy:
Gomes LC; Health and Sport Science Center, Federal University of Acre, Rio Branco, Acre, Brazil.
Sanson MCG; Multidisciplinary Center, Federal University of Acre, Cruzeiro do Sul, Acre, Brazil.
Brainin P; Herlev-Gentofte University Hospital, Hellerup, Denmark.
de Melo MDCV; Multidisciplinary Center, Federal University of Acre, Cruzeiro do Sul, Acre, Brazil.
de Souza RM; Multidisciplinary Center, Federal University of Acre, Cruzeiro do Sul, Acre, Brazil.
Mazaro J; Laboratory of Public Health of Acre, Acre, Brazil.
Lima KO; Multidisciplinary Center, Federal University of Acre, Cruzeiro do Sul, Acre, Brazil.
Resende JS; Multidisciplinary Center, Federal University of Acre, Cruzeiro do Sul, Acre, Brazil.
Vieira IVM; Multidisciplinary Center, Federal University of Acre, Cruzeiro do Sul, Acre, Brazil.
Mesquita EDS; Multidisciplinary Center, Federal University of Acre, Cruzeiro do Sul, Acre, Brazil.
Matos LO; Multidisciplinary Center, Federal University of Acre, Cruzeiro do Sul, Acre, Brazil.
Dutra ICS; Multidisciplinary Center, Federal University of Acre, Cruzeiro do Sul, Acre, Brazil.
Palmisano G; Department of Parasitology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
Wrenger C; Department of Parasitology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
Marinho CRF; Department of Parasitology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
da Silva RDSU; Health and Sport Science Center, Federal University of Acre, Rio Branco, Acre, Brazil.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Jul 01; Vol. 16 (7), pp. e0253752. Date of Electronic Publication: 2021 Jul 01 (Print Publication: 2021).
Typ publikacji:
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunization Schedule*
Hepatitis B/*immunology
Hepatitis B Antibodies/*blood
Hepatitis B virus/*immunology
Age Factors ; Brazil ; Child, Preschool ; Cross-Sectional Studies ; Endemic Diseases/prevention & control ; Female ; Hepatitis B/blood ; Hepatitis B/prevention & control ; Hepatitis B/virology ; Hepatitis B Antibodies/immunology ; Hepatitis B Surface Antigens/immunology ; Hepatitis B Vaccines/administration & dosage ; Hepatitis B Vaccines/immunology ; Humans ; Male ; Mass Vaccination ; Serologic Tests/statistics & numerical data ; Time Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Lack of awareness of Hepatitis B screening and vaccination in high-risk groups
Autorzy:
Balaban HY; Department of Gastroenterology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
Aslan AT; Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey
Ayar ŞN; Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey
Dağ O; Department of Biostatistics, Faculty of Medicine, Hacettepe University, Ankara, Turkey
Alp A; Department of Microbiology and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
Şimşek C; Department of Gastroenterology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
Vahabov C; Department of Gastroenterology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
Yıldırım T; Department of Nephrology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
Göker H; Department of Hematology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
Büyükaşık Y; Department of Hematology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
Şimşek H; Department of Gastroenterology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
Pokaż więcej
Źródło:
Turkish journal of medical sciences [Turk J Med Sci] 2021 Jun 28; Vol. 51 (3), pp. 1229-1233. Date of Electronic Publication: 2021 Jun 28.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B*/diagnosis
Hepatitis B*/epidemiology
Hepatitis B*/prevention & control
Hepatitis B Antibodies*
Hepatitis B Surface Antigens ; Hepatitis B Vaccines ; Hepatitis B virus ; Humans ; Vaccination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The Role of Antiviral Prophylaxis in Preventing HBV and HDV Recurrence in the Setting of Liver Transplantation.
Autorzy:
Battistella S; Gastroenterology and Multivisceral Transplant Unit, Azienda Ospedale-Università di Padova, 35128 Padova, Italy.; Department of Surgery, Oncology and Gastroenterology, University of Padua, Via Giustiniani 2, 35128 Padova, Italy.
Zanetto A; Gastroenterology and Multivisceral Transplant Unit, Azienda Ospedale-Università di Padova, 35128 Padova, Italy.; Department of Surgery, Oncology and Gastroenterology, University of Padua, Via Giustiniani 2, 35128 Padova, Italy.
Gambato M; Gastroenterology and Multivisceral Transplant Unit, Azienda Ospedale-Università di Padova, 35128 Padova, Italy.
Germani G; Gastroenterology and Multivisceral Transplant Unit, Azienda Ospedale-Università di Padova, 35128 Padova, Italy.
Senzolo M; Gastroenterology and Multivisceral Transplant Unit, Azienda Ospedale-Università di Padova, 35128 Padova, Italy.
Burra P; Gastroenterology and Multivisceral Transplant Unit, Azienda Ospedale-Università di Padova, 35128 Padova, Italy.; Department of Surgery, Oncology and Gastroenterology, University of Padua, Via Giustiniani 2, 35128 Padova, Italy.
Russo FP; Gastroenterology and Multivisceral Transplant Unit, Azienda Ospedale-Università di Padova, 35128 Padova, Italy.; Department of Surgery, Oncology and Gastroenterology, University of Padua, Via Giustiniani 2, 35128 Padova, Italy.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Apr 23; Vol. 15 (5). Date of Electronic Publication: 2023 Apr 23.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Liver Transplantation*/adverse effects
Hepatitis B*/drug therapy
Hepatitis B*/prevention & control
Carcinoma, Hepatocellular*
Liver Neoplasms*
Humans ; Hepatitis B virus ; Hepatitis Delta Virus ; Antiviral Agents/therapeutic use ; Hepatitis B Surface Antigens ; Immunoglobulins/therapeutic use ; Treatment Outcome ; Neoplasm Recurrence, Local ; Hepatitis B Antibodies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Kinetics and predictive value of HBcrAg, HBV RNA and anti-HBc during bulevirtide treatment of chronic HDV-infected patients.
Autorzy:
Sandmann L; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.; Excellence Cluster RESIST, Excellence Initiative Hannover Medical School, Hannover, Germany.
Deterding K; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
Bremer B; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
Port K; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
Cornberg M; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.; Excellence Cluster RESIST, Excellence Initiative Hannover Medical School, Hannover, Germany.; German Center for Infection Research (DZIF), Hannover, Braunschweig, Germany.; Center for Individualised Infection Medicine, Helmholtz Center for Infection Research, Braunschweig, Germany.
Wedemeyer H; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.; Excellence Cluster RESIST, Excellence Initiative Hannover Medical School, Hannover, Germany.; German Center for Infection Research (DZIF), Hannover, Braunschweig, Germany.
Maasoumy B; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.; German Center for Infection Research (DZIF), Hannover, Braunschweig, Germany.
Pokaż więcej
Źródło:
Journal of viral hepatitis [J Viral Hepat] 2023 Apr; Vol. 30 (4), pp. 283-286. Date of Electronic Publication: 2023 Jan 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis B, Chronic*/drug therapy
Hepatitis D, Chronic*/drug therapy
Hepatitis D*/drug therapy
Humans ; Hepatitis B Core Antigens ; Hepatitis B virus/genetics ; Hepatitis Delta Virus/genetics ; RNA ; Hepatitis B Antibodies ; Antiviral Agents/therapeutic use ; DNA, Viral/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A Novel Insertion in the Hepatitis B Virus Surface Protein Leading to Hyperglycosylation Causes Diagnostic and Immune Escape.
Autorzy:
Lehmann F; Institute of Medical Virology, National Reference Center for Hepatitis B Viruses and Hepatitis D Viruses, German Center for Infection Research (DZIF; Partner Site Giessen-Marburg-Langen), Justus Liebig University, 35392 Giessen, Germany.
Slanina H; Institute of Medical Virology, National Reference Center for Hepatitis B Viruses and Hepatitis D Viruses, German Center for Infection Research (DZIF; Partner Site Giessen-Marburg-Langen), Justus Liebig University, 35392 Giessen, Germany.
Roderfeld M; Department of Gastroenterology, Justus Liebig University, 35392 Giessen, Germany.
Roeb E; Department of Gastroenterology, Justus Liebig University, 35392 Giessen, Germany.
Trebicka J; Department of Medicine B, University Hospital Muenster, 48149 Muenster, Germany.
Ziebuhr J; Institute of Medical Virology, National Reference Center for Hepatitis B Viruses and Hepatitis D Viruses, German Center for Infection Research (DZIF; Partner Site Giessen-Marburg-Langen), Justus Liebig University, 35392 Giessen, Germany.
Gerlich WH; Institute of Medical Virology, National Reference Center for Hepatitis B Viruses and Hepatitis D Viruses, German Center for Infection Research (DZIF; Partner Site Giessen-Marburg-Langen), Justus Liebig University, 35392 Giessen, Germany.
Schüttler CG; Institute of Medical Virology, National Reference Center for Hepatitis B Viruses and Hepatitis D Viruses, German Center for Infection Research (DZIF; Partner Site Giessen-Marburg-Langen), Justus Liebig University, 35392 Giessen, Germany.
Schlevogt B; Department of Medicine B, University Hospital Muenster, 48149 Muenster, Germany.; Department of Gastroenterology, Medical Center Osnabrueck, 49076 Osnabrueck, Germany.
Glebe D; Institute of Medical Virology, National Reference Center for Hepatitis B Viruses and Hepatitis D Viruses, German Center for Infection Research (DZIF; Partner Site Giessen-Marburg-Langen), Justus Liebig University, 35392 Giessen, Germany.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Mar 25; Vol. 15 (4). Date of Electronic Publication: 2023 Mar 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis B, Chronic*
Hepatitis B*
Humans ; Hepatitis B virus/genetics ; Hepatitis B Surface Antigens/genetics ; Hepatitis B Antibodies ; Hepatitis B Vaccines ; Mutation ; Immunologic Factors ; Nucleotides ; Membrane Proteins/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Incidence, risk factors, and clinical outcomes of HBV reactivation in non-liver solid organ transplant recipients with resolved HBV infection: A systematic review and meta-analysis.
Autorzy:
Yin S; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu City, Sichuan Province, China.; Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu City, Sichuan Province, China.
Zhang F; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu City, Sichuan Province, China.; Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu City, Sichuan Province, China.
Wu J; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu City, Sichuan Province, China.; Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu City, Sichuan Province, China.
Lin T; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu City, Sichuan Province, China.; Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu City, Sichuan Province, China.
Wang X; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu City, Sichuan Province, China.; Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu City, Sichuan Province, China.
Pokaż więcej
Źródło:
PLoS medicine [PLoS Med] 2023 Mar 15; Vol. 20 (3), pp. e1004196. Date of Electronic Publication: 2023 Mar 15 (Print Publication: 2023).
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis B*/epidemiology
Hepatitis B*/drug therapy
Organ Transplantation*/adverse effects
Humans ; Hepatitis B virus/physiology ; Rituximab/therapeutic use ; Retrospective Studies ; Incidence ; Antiviral Agents/therapeutic use ; Risk Factors ; Hepatitis B Antibodies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas.
Autorzy:
Lan TY; Division of Rheumatology, Department of Internal Medicine, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan.
Lin YC; Department of Internal Medicine, National Taiwan University Hospital Yun-Lin Branch, Douliu, Taiwan.
Tseng TC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Yang HC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Kao JH; Department of Internal Medicine, National Taiwan University Hospital Yun-Lin Branch, Douliu, Taiwan.
Cheng CF; Department of Internal Medicine, National Taiwan University Hospital Yun-Lin Branch, Douliu, Taiwan.
Lee TJ; Division of Rheumatology, Department of Internal Medicine, National Taiwan University, Taipei, Taiwan.
Huang SC; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital Bei-Hu Branch, Taipei, Taiwan.
Lu CH; Division of Rheumatology, Department of Internal Medicine, National Taiwan University, Taipei, Taiwan.
Li KJ; Division of Rheumatology, Department of Internal Medicine, National Taiwan University, Taipei, Taiwan.
Hsieh SC; Division of Rheumatology, Department of Internal Medicine, National Taiwan University, Taipei, Taiwan.
Pokaż więcej
Źródło:
Gut and liver [Gut Liver] 2023 Mar 15; Vol. 17 (2), pp. 288-298. Date of Electronic Publication: 2022 Oct 21.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B, Chronic*/complications
Hepatitis B*/drug therapy
Autoimmune Diseases*/drug therapy
Infant, Newborn ; Humans ; Hepatitis B virus ; Rituximab/therapeutic use ; Hepatitis B Surface Antigens ; Retrospective Studies ; Symptom Flare Up ; Hepatitis B Antibodies ; Virus Activation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Atypical serologic profiles of hepatitis B virus infection across clinical cohorts of patients in Southwestern Nigeria.
Autorzy:
Osasona OG; Department of Biological Sciences, Redeemer's University, Ede, Nigeria.
Oguntoye T; Department of Medicine, Federal Teaching Hospital Ido- Ekiti, Federal Teaching Hospital Ido-Ekiti, Ido Ekiti, Nigeria.
Eromon P; African Center of Excellence for Genomics of Infectious diseases Redeemer's University, Redeemer's University Ede, Ede, Nigeria.
Abdulkareem L; Department of Medicine, University of Abuja Teaching Hospital, Gwagwalada, Nigeria.
Arowosaye AO; Department of Virology, University of Ibadan, Ibadan, Nigeria.
Ariyo OE; Department of Medicine, Federal Teaching Hospital Ido- Ekiti, Federal Teaching Hospital Ido-Ekiti, Ido Ekiti, Nigeria.
George UE; Department of Biological Sciences, Redeemer's University, Osun, Nigeria.
Yusuf M; Department of Medicine, Federal Teaching Hospital Ido- Ekiti, Federal Teaching Hospital Ido-Ekiti, Ido Ekiti, Nigeria.
Adewumi OM; Department of Virology, University College Hospital, Ibadan, Nigeria.
Happi C; African Centre of Excellence for Genomics of Infectious Diseases, Department of Biological Sciences, Redeemers University, Ede, Nigeria.
Folarin OA; Department of Biological Sciences, Redeemer's University, Ede, Nigeria.
Pokaż więcej
Źródło:
Journal of immunoassay & immunochemistry [J Immunoassay Immunochem] 2023 Mar 04; Vol. 44 (2), pp. 176-191. Date of Electronic Publication: 2023 Jan 22.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B virus*
Hepatitis B*
Male ; Female ; Humans ; Young Adult ; Adult ; Middle Aged ; Hepatitis B Surface Antigens ; Hepatitis B e Antigens ; DNA, Viral/analysis ; Nigeria/epidemiology ; Cross-Sectional Studies ; Hepatitis B Antibodies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Hepatitis B infection among β-thalassemia major patients in Bushehr province of southern Iran.
Autorzy:
Farshadpour F; Department of Virology, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran.
Taherkhani R; Department of Virology, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran.
Farajzadeh H; Department of Virology, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran.
Pokaż więcej
Źródło:
Journal of immunoassay & immunochemistry [J Immunoassay Immunochem] 2023 Mar 04; Vol. 44 (2), pp. 147-161. Date of Electronic Publication: 2023 Jan 01.
Typ publikacji:
Journal Article
MeSH Terms:
beta-Thalassemia*
Hepatitis B*/epidemiology
Hepatitis B, Chronic*
Humans ; Hepatitis B Surface Antigens ; Iran ; Viremia/complications ; Seroepidemiologic Studies ; Hepatitis B virus ; Hepatitis B Antibodies ; Prevalence
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Sero-prevalence of hepatitis B virus and compliance with hepatitis B vaccination schedules among outpatient clinic attendees in Nairobi.
Autorzy:
Langat B; Department of Medical Biochemistry, University of Nairobi, Nairobi, Kenya.
Muge EK; Department of Medical Biochemistry, University of Nairobi, Nairobi, Kenya.
Night D; Centre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya.
Okoth F; Centre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya.
Ochwedo KO; Faculty of Science and Technology, Department of Biology, University of Nairobi, Nairobi, Kenya.
Songok EM; Centre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Feb 02; Vol. 18 (2), pp. e0281256. Date of Electronic Publication: 2023 Feb 02 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis B*/epidemiology
Hepatitis B*/prevention & control
Hepatitis B*/drug therapy
Hepatitis B Vaccines*/administration & dosage
Vaccination*/statistics & numerical data
Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Female ; Humans ; Middle Aged ; Young Adult ; Hepatitis B Antibodies ; Hepatitis B Surface Antigens ; Hepatitis B virus ; Kenya/epidemiology ; Prevalence ; Male
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Risk of hepatitis B reactivation in HBsAg-/HBcAb+ patients after biologic or JAK inhibitor therapy for rheumatoid arthritis: A meta-analysis.
Autorzy:
Hong X; Department of Rheumatology and Immunology, The First Affiliated Hospital of Guilin Medical University, Guilin, People's Republic of China.
Xiao Y; Department of Rheumatology and Immunology, The First Affiliated Hospital of Guilin Medical University, Guilin, People's Republic of China.
Xu L; Tianjin hospital, Tianjin, China.
Liu L; Department of Rheumatology and Immunology, The First Affiliated Hospital of Guilin Medical University, Guilin, People's Republic of China.
Mo H; Department of Rheumatology and Immunology, The First Affiliated Hospital of Guilin Medical University, Guilin, People's Republic of China.
Mo H; Department of Rheumatology and Immunology, The First Affiliated Hospital of Guilin Medical University, Guilin, People's Republic of China.
Pokaż więcej
Źródło:
Immunity, inflammation and disease [Immun Inflamm Dis] 2023 Feb; Vol. 11 (2), pp. e780.
Typ publikacji:
Systematic Review; Meta-Analysis; Journal Article; Review
MeSH Terms:
Arthritis, Rheumatoid*/drug therapy
Biological Products*/adverse effects
Biological Products*/therapeutic use
Hepatitis B*/chemically induced
Hepatitis B*/drug therapy
Janus Kinase Inhibitors*/adverse effects
Janus Kinase Inhibitors*/therapeutic use
Humans ; Hepatitis B Antibodies ; Hepatitis B Surface Antigens ; Hepatitis B virus/physiology ; Interleukin-6 ; Rituximab/adverse effects ; Rituximab/therapeutic use ; Tumor Necrosis Factor-alpha
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparative analysis of hepatitis B virus infections in blood donors born before and after the implementation of universal HBV vaccination in southern China.
Autorzy:
Ye X; Department of Laboratory, Shenzhen Blood Centre, Shenzhen, China.
Li T; Department of Laboratory, Shenzhen Blood Centre, Shenzhen, China.
Li Y; Department of Laboratory, Shenzhen Blood Centre, Shenzhen, China.
Zeng J; Department of Laboratory, Shenzhen Blood Centre, Shenzhen, China.
Li R; Department of Laboratory, Shenzhen Blood Centre, Shenzhen, China.
Xu X; Department of Laboratory, Shenzhen Blood Centre, Shenzhen, China.
Guan X; Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China.; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, China.; School of Public Health, Anhui Medical University, Hefei, China.
Li L; Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China.; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, China.; School of Public Health, Anhui Medical University, Hefei, China.
Pokaż więcej
Źródło:
Transfusion medicine (Oxford, England) [Transfus Med] 2023 Feb; Vol. 33 (1), pp. 81-89. Date of Electronic Publication: 2022 Aug 16.
Typ publikacji:
Journal Article
MeSH Terms:
Blood Donors*
Hepatitis B*/epidemiology
Hepatitis B virus*/genetics
Humans ; China/epidemiology ; DNA, Viral ; Hepatitis B Antibodies ; Hepatitis B Surface Antigens ; Hepatitis B Vaccines ; Real-Time Polymerase Chain Reaction ; Vaccination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Changes in the hepatitis B surface antibody in childhood acute lymphocytic leukaemia survivors after treatment with the CCLG-ALL 2008 protocol.
Autorzy:
Wang L; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education; Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Hu H; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education; Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Zhang R; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education; Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Zheng X; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education; Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Li J; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education; Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Lu J; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education; Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Zhang Y; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education; Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Qi P; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education; Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Lin W; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education; Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Wu Y; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education; Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Yu J; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education; Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Fan J; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education; Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Peng Y; Center for Clinical Epidemiology and Evidence-Based Medicine, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Zheng H; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education; Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Pokaż więcej
Źródło:
Clinical and experimental immunology [Clin Exp Immunol] 2021 Jan; Vol. 203 (1), pp. 80-86. Date of Electronic Publication: 2020 Oct 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cancer Survivors*
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Hepatitis B/*immunology
Hepatitis B Antibodies/*immunology
Hepatitis B Surface Antigens/*immunology
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*immunology
Child ; Child, Preschool ; Hepatitis B/blood ; Hepatitis B Antibodies/blood ; Hepatitis B Surface Antigens/blood ; Humans ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/blood
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Occult Hepatitis B virus infection among HIV negative and positive isolated anti-HBc individuals in eastern Ethiopia.
Autorzy:
Ayana DA; College of Health and Medical Sciences, Haramaya University, Haramaya, Ethiopia. .; Armauer Hansen Research Institute, Addis Ababa, Ethiopia. .
Mulu A; College of Health and Medical Sciences, Haramaya University, Haramaya, Ethiopia.; Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Mihret A; College of Health and Medical Sciences, Haramaya University, Haramaya, Ethiopia.; Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Seyoum B; College of Health and Medical Sciences, Haramaya University, Haramaya, Ethiopia.; Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Aseffa A; College of Health and Medical Sciences, Haramaya University, Haramaya, Ethiopia.; Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Howe R; College of Health and Medical Sciences, Haramaya University, Haramaya, Ethiopia.; Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Dec 17; Vol. 10 (1), pp. 22182. Date of Electronic Publication: 2020 Dec 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Coinfection/*epidemiology
HIV Infections/*epidemiology
Hepatitis B/*epidemiology
Hepatitis B/*immunology
Hepatitis B Antibodies/*immunology
Adolescent ; Adult ; Aged ; CD4 Lymphocyte Count ; Coinfection/immunology ; Ethiopia/epidemiology ; Female ; HIV Infections/immunology ; HIV Infections/transmission ; HIV Infections/virology ; Hepatitis B/transmission ; Hepatitis B/virology ; Hepatitis B Antibodies/blood ; Hepatitis B Core Antigens/immunology ; Hepatitis B virus/immunology ; Humans ; Male ; Middle Aged ; Public Health Surveillance ; Viral Load ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Occult hepatitis B infection in vaccinated children with negative anti-HBc, true or not?
Autorzy:
Zhou YH; Departments of Laboratory Medicine and Infectious Diseases, Nanjing Drum Tower Hospital and Jiangsu Key Laboratory for Molecular Medicine, Nanjing University Medical School, Nanjing, China.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2020 Oct; Vol. 40 (10), pp. 2570. Date of Electronic Publication: 2020 May 14.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't; Comment
MeSH Terms:
Hepatitis B Antibodies*
Hepatitis B, Chronic*
Child ; Humans ; Iran ; Parents ; Prevalence
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 21-40 z 967

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies